Shopping Cart (0)
My Account

Your Shopping Cart
Point-of-Care Diagnostics World CongressExosomes & Single Cell Analysis SummitLab-on-a-Chip, Microfluidics & Microarray World CongressAcademic Discovery WorkshopAdvances in Plant Genomics - Online Event20% Discount OfferePoster Award PrizeBlogs

Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine

Publisher: Select Biosciences
Published: April 2010
Pages: 52


This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem cells field. This bottom-up analysis highlights market trends operative and enables the identification of trends vis-a-vis the research marketplace, utilization of different classes of stem cells, as well as the penetrance of different research product vendors into specific segments of the stem cells marketplace.

This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our analysis of this space provides up-to-date qualitative and quantitative market metrics. Primary Market Data Provide a Comprehensive and Bottom-Up Picture of the marketplace for the utilization of stem cells for drug discovery/toxicity screening efforts as well as research for regenerative medicine applications.

Specific Topics Covered in this Trends Report:

  • Primary and Up-to-Date Market Survey from a Worldwide Cross Section of the Stem Cells Industry Participants
  • Quantitative Market Penetration of Vendors Offering Products (in various segments) to the Stem Cells Research Community
  • Utilization Trends of Different Classes of Stem Cells for Drug Discovery/Toxicity Screening and Associated Trends
  • Penetrance of hESCs and iPSCs in Drug Discovery/Toxicity Screening
  • Currently Commercialized Products and Services Utilizing Stem Cells for Drug Discovery/Toxicity Screening
  • Activities Utilizing Stem Cells for Research Efforts in Regenerative Medicine
  • Cardiovascular Disease and CNS Disease Research Trends vis-a-vis Utilization of Stem Cells

This data-driven characterization of the stem cells market landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development-all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling "drag-and-drop" into business presentations or business plans.

Report Table of Contents (TOC) [Click Here to Download PDF File]

For enquiries about this market report, please contact Kathy Gray at

Conference News
Keynote Speaker Confirmed, Stephen Minger
We are thrilled to announce that Stephen Minger, Global Director of GE Healthcare, has confirmed he will be giving a keynote presentation at Stem Cells in Drug Discovery 2015.

Site Visit to the SIMTech Microfluidics Foundry
Site Visit to the SIMTech Microfluidics Foundry
Take advantage of a tour of the facilities at the SIMTech Microfluidic Foundry. Dr. Zhiping Wang, Director of Research Programmes, will be your host, providing all attendees with a detailed insight into the advanced work carried out by SIMTech. Don't miss out - Register today!

“The Medical Association of Saxony certificates the two-day congress with 16 continuing education points.”

Call for papers - Advances in qPCR and dPCR 2015, Singapore
Call for papers - Advances in qPCR and dPCR 2015, Singapore
We are now accepting papers for the Advances in qPCR and dPCR meeting which will take place on the 21-22 May 2015 in Singapore.

Keynote Speakers Confirmed, Carlos Caldas and Mark Caulfield
We are thrilled to announce that Professor Carlos Caldas, Group Leader at the Cancer Research UK Cambridge Institute and Professor Mark Caufield, Chief Scientist of the Genomics England 100,000 project, have both confirmed their keynote presentations at Personalized Medicine in May 2015, Cambridge.

Submission Deadline Extended to the 15 August 2014
Submission Deadline Extended to the 15 August 2014
Submit your abstract for consideration to present at Lab-on-a-Chip Asia - Microfluidics and Point-of-Care Diagnostics.

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter